The Novartis Venture Fund was founded in 1996, making it one of the oldest pharma CVCs still operating. With $750M+ in committed capital, the fund maintains a portfolio of 40+ active investments from a total of 163 over 25+ years.
Check sizes start at $100K and can reach $30-50M per company over the investment lifetime. The track record includes 24 IPOs and 62 acquisitions. Dual offices in Basel ...
New York, United States
Basel, Switzerland
Paris, France
London, United Kingdom
Melbourne, Australia
Leverkusen, Germany